The extracellular functional activity of AGR2 has been demonstrated to impact the EGFR growth stimulation pathway and promote the generation of exosomes, as well as the ubiquitin ligase family member TSG101, which inhibits p53 function and activates the ERK1/2-MAPK pathway to facilitate tumor growth and metastasis. Here, AGR2 is linked to neoplasm.